Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Sitagliptin and metformin hydrochloride
Medication labelSitagliptin and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with…
Why this: Advisory · dailymed-prescription
Sitagliptin and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use Sitagliptin and metformin hydrochloride tablets should not be used in patients with type 1 diabetes mellitus. Sitagliptin and metformin hydrochloride tablets have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using sitagliptin and metformin hydrochloride tablets [see Warnings and Precautions (5.2)].
- generic_name
- sitagliptin and metformin hydrochloride
- product_names
- Sitagliptin and Metformin Hydrochloride
- ndc
- 84677-052, 84677-053, 60505-3658, 84677-052-60, 84677-052-18, 60505-3659, 84677-053-60, 84677-053-18
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en